ACAngela W. Chen

Angela W. Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Angela W. Chen has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Discrimination Against Asian Americans and its Impact on Lifestyle Risk Factors for Cardiovascular Disease: A Scoping Review

    by Raymond Hsu, Angela W. Chen, Kris Pui Kwan Ma, Eugene Yang

    Cardiovascular disease mortality among Asian American subgroups has worsened in recent decades. One understudied contributor is the role of discrimination and its impact on lifestyle risk factors that influence cardiovascular health. This scoping review synthesizes the literature on the associations between interpersonal discrimination and three key lifestyle risk factors that are crucial to cardiovascular health: smoking, exercise, and sleep. We searched four databases (PubMed/Embase/CINAHL Complete/PsycINFO) for studies published prior to 2/13/2026, supplemented by hand-searching reference lists of included articles. Eligible studies explored the association between interpersonal discrimination and smoking, exercise, or sleep among Asian Americans. Our search returned 1,935 studies, of which 1,912 were excluded. We conducted a full-text review with 23 articles, yielding 16 eligible studies. Five studies examined discrimination and smoking, three examined discrimination and exercise, and 10 examined discrimination and sleep health. Many of the included studies had small samples, varied methods, and high risk of bias. Among these risk factors, most of the evidence suggests poor sleep health is related to discrimination against Asian Americans. Interpersonal discrimination is linked to adverse lifestyle risk factors, especially poor sleep health, highlighting underrecognized contributors to cardiovascular health disparities among Asian Americans. Larger studies that disaggregate Asian American subgroups with validated assessments of discrimination and related risk behaviors are needed, along with more language-concordant surveys to better capture the experiences of those with limited English proficiency. Healthcare professionals, public health officials, and researchers must work collaboratively to address discrimination and reduce its harmful downstream effects.

  • Effects of Medicaid Expansion on HPV Vaccination Uptake Among Adolescents in the United States: Difference-in-Differences Analyses From 2011 to 2022

    by Angela W. Chen, Taryn L. Amberson, Harriet Fridah Adhiambo, Bradley H. Wagenaar

    Objectives. To determine if Medicaid expansion was associated with increased human papillomavirus (HPV) vaccination among adolescents in the United States. Methods. We conducted a quasi-experimental study using generalized difference-in-differences on National Immunization Survey‒Teen data from 2011 to 2022 among adolescents aged 13 to 17 years, comparing HPV vaccination in Medicaid expansion states to nonexpansion states by sex and race/ethnicity subgroups. Results. There was a significant 10.1-percentage-point increase in HPV vaccination among male adolescents in expansion states (95% confidence interval [CI] = 8.9, 12.4; P < .001). Significant increases in HPV vaccination were observed among all male racial subgroups, with largest effects among Black, Latino, and other or multiple races. No effect was observed among female adolescents or any racial subgroup. Conclusions. Medicaid expansion was associated with significant increases in HPV vaccination among male adolescents, with no effects observed among female adolescents. All male race/ethnicity subgroups showed increases, with Black, Latino, and other or multiple race/ethnicity male adolescents having the largest effect. Public Health Implications. Medicaid expansion is an appropriate and effective policy for increasing HPV vaccination uptake for priority populations, including historically marginalized racial/ethnic groups and male adolescents. ( Am J Public Health. Published online ahead of print June 26, 2025:e1–e9. https://doi.org/10.2105/AJPH.2025.308165 )


  • Interventions and Strategies for Reducing Episiotomy Rates Globally: A Systematic Review

    by Angela W. Chen, Maiah J. Hall, Molly R. Altman

    Introduction: Episiotomy is still commonly practiced during childbirth worldwide, despite decades of scientific evidence that indicates no justification for its routine use. Routine episiotomy is associated with increased risk of serious maternal morbidity and no improvements in neonatal outcomes. We sought to analyze this gap between evidence‐based knowledge and implementation surrounding reducing episiotomy practice. We systematically reviewed the literature to identify practices that have resulted in a change in episiotomy rates. Methods: We searched three databases (PubMed/MEDLINE, CINAHL Complete, Embase) using key words and subject headings with no time restriction. Any studies published in English and reporting an original empirical analysis in any global, regional, or country‐specific context that examined practice changes that were implemented and reported episiotomy as an outcome were included in our review. Studies were excluded if they only reported on trends or changes in episiotomy rates without examining the specific practices implemented. We sought to identify practices that resulted in a change in episiotomy rates, rather than to evaluate or compare the effectiveness of these practices. Results: Search results returned 1265 records; 40 papers met the inclusion criteria for a full review. Twenty‐five papers were included in our final analysis. All included studies documented a decrease in episiotomy rates, with 21 studies reporting a statistically significant reduction. Most studies were mixed interventions, often a combination of an educational intervention and audit and feedback. Conclusions: Specific practice changes have been shown to effectively decrease the incidence of episiotomy. The findings from our review provide actionable insights for implementing evidence‐based interventions to improve obstetric care. Prioritizing respectful birthing practices and reducing the routine use of episiotomy are critical steps toward addressing obstetric violence and promoting equitable, patient‐centered maternity care globally.


  • Cost-Effectiveness Analysis of E-cigarettes Compared to Nicotine Replacement Therapy for Smoking Cessation Among Medicaid Users in California

    by Angela W Chen, Paul A Fishman

    Introduction: Smoking is the leading preventable cause of death and disability in the United States. A 2019 randomized controlled trial found e-cigarettes are more effective than nicotine replacement therapy (NRT) in achieving abstinence when both are combined with behavioral counseling. Few cost-effectiveness studies have been performed regarding e-cigarettes as an adjunct to cessation efforts, and none in a U.S. context. This study evaluated the cost-effectiveness of e-cigarettes compared to NRT, both with counseling, and as cessation aids for Medicaid smokers in California. Aims and Methods: A cost-effectiveness analysis from a U.S. societal perspective comparing e-cigarettes with NRT was constructed. Using a lifetime horizon, smokers were followed to different health states to their expected lifespan. Costs were expressed in 2020 U.S. dollars and health outcomes in quality-adjusted life years (QALY). All costs and outcomes were discounted at a 3% annual rate and model findings were assessed with a series of sensitivity analyses. Results: Using U.S. willingness-to-pay thresholds, e-cigarettes were more cost-effective than NRT, with an incremental cost-effectiveness ratio of $11 454 per additional QALY gained over smokers’ lifetimes. Results were sensitive to smokers’ healthcare costs, model start ages, discount rates, and QALY weights. Conclusions: E-cigarettes used as a cessation treatment by smokers are more cost-effective relative to NRT. However, e-cigarettes as a treatment are currently unapproved by the Food and Drug Administration (FDA). Despite the lack of FDA approval, e-cigarettes are a popular choice among smokers trying to quit. Policymakers should consider whether providing financial support for e-cigarettes as a harm reduction strategy is worth pursuing. Implications: As e-cigarettes grow in popularity and are an increasingly preferred choice of smoking cessation aid among smokers attempting to quit, it is important to examine the inclusion of these products in tobacco policy, research, and practice. Several countries have now adopted or are in the process of adopting e-cigarettes as a medically licensed and regulated smoking cessation aid. Future smoking cessation strategies by U.S. policymakers may consider the adoption of e-cigarettes as a cost-effective harm reduction tool for use by current smokers seeking to quit.